Kamfanonin inshora na kiwon lafiya sun ba da damar ɗaukar hoto ne kawai don kiwon lafiya da ke da alaka da su. Medicare, alal misali, ya bayyana ainihin wajibi ne kamar: "Ayyuka ko kayan da ake buƙatar don ganewar asali ko magance lafiyar lafiyar ku da kuma cika ka'idodin aikin likita."
Sanarwar likita tana nufin yanke shawara ta shirin lafiyarka cewa lafiyarka, gwaji, ko tsari ya zama dole don lafiyarka ko kuma kula da matsalar lafiya.
Yawancin tsare-tsare na kiwon lafiya ba zai biya wa ma'aikatan kiwon lafiyar da suke tsammanin ba su da lafiya. Misalin mafi yawan al'ada shi ne tsari na kwaskwarima, kamar su allurar magungunan (kamar Botox ) don rage gwanon fuska ko kuma tiyata. Yawancin kamfanonin inshora na kiwon lafiya ba za su rufe hanyoyin da suka ƙaddara su zama gwaji ko ba a tabbatar su yi aiki ba.
Amfani da Gidajen Marijuana
Yin amfani da marijuana don dalilai na kiwon lafiya shine lamarin 'likita'. Cannabis itace tsire-tsire tare da sinadaran aikin da masu fama ya yadu a yadu su zama masu tasiri a cikin kulawa da jin zafi saboda yanayi daban-daban, yawanci ne a cikin yanayi, inda magunguna na yau da kullum basu yi aiki sosai ba.
Maganar likita ta farko ta zama doka a karkashin dokar jihar tare da amincewar 215 a California ta 1996. A watan Nuwamba 2017, akwai jihohi 29 da suka halatta yin amfani da cutar cannabis.
Duk da haka, a matsayin Jigilar I magani a ƙarƙashin Dokar Magunguna, Dokar marijuana ba ta da doka a karkashin dokar tarayya. Jirgin I na magungunan ƙwayoyi sun bayyana ta hanyar Dokar Kula da Harkokin Kiwon Lafiyar da ke da "ba a yi amfani da magani ba a halin yanzu da kuma babbar matsala ga zagi." Abin sha'awa, cocaine da methamphetamine duka sune aka tsara a matsayin jigilar II, suna sa su suyi amfani da tsarin tsarin DEA don tsara "likita mai kyau da amfani da magungunan miyagun ƙwayoyi."
Har yanzu FDA ba ta yarda da Marijuana ba, saboda bangarorinta na jigilar Hadafi 1 sun sa da wuya ga FDA ta gudanar da gwaje-gwaje masu dacewa don ƙayyade aminci da inganci. A cikin shekaru arba'in da suka gabata, an sake yin shawarwari akai-akai domin canza jerin jinsin Jirgin 1 na marijuana, amma kamar yadda Agusta ta 2016, DEA ya ki canza canjin.
Amma DEA ta yarda, don ƙãra yawan wuraren da DEA ta amince da ita don bunkasa marijuana don dalilai na bincike. A baya, akwai ɗaya (a Jami'ar Mississippi), amma DEA ta lura cewa wasu masu ba da izini sun yarda su samar da masu bincike na FDA tare da "samar da marijuana da yawa."
Amma a halin yanzu, duk da haka, saboda yadda ake amfani da marijuana a matsayin jima'i na I likitanci (tare da "ba a yarda da ita ba a halin yanzu"), da rashin bin doka a ƙarƙashin dokokin tarayya, da kuma rashin amincewa da FDA, tsare-tsaren inshora na kiwon lafiya ba su rufe marijuana, ko da kuwa dokar doka ta tsammaci doka ne, kuma ko da kuwa likita ya fi tsammanin shi ya zama dole.
Bincika tare da Shirin Kiwon Lafiya
Yana da mahimmanci ka tuna cewa abin da kai ko likitanka ya bayyana kamar yadda yake da mahimmanci yana iya zama ba daidai da ka'idodin tsarin lafiyar lafiyar ku ba.
Kafin ka sami wani tsari, musamman ma wanda yake da tsada mai tsada, duba littafin amfanarka don tabbatar da an rufe shi. Idan ba ku da tabbacin, kira wakilin wakilin sabis na lafiyar ku.
Fahimci Dancinka na Kira
Shirye-shiryen kiwon lafiya sunyi matakan sakonni (sun fi ƙarfin aiki a karkashin Dokar Kulawa ta Kasuwanci) wanda ya ba da damar marasa lafiya da likitoci su yi roko lokacin da aka dakatar da neman izini. Duk da yake babu wata tabbacin cewa tayin zai yi nasara, ACA ta tabbatar da hakkinka ga nazarin na waje idan ba'a yi nasara ba ta hanyar binciken da kake ciki a cikin tsarin kula da lafiyar ku.
> Sources:
> BallotPedia, California Shawarwarin 215, Cibiyar Nazari ta Maryjuana (1996).
> Ƙarin Shawarar Masarauta, Jagoran Mai Amfani don Bincike Tsarin Shawarar Assurance .
> Gwamnatin Amirka ta Gudanar da Harkokin Kiwon Lafiyar Jama'a, DEA ta sanar da Ayyuka da suka shafi Maganar Marijuana da Industrial Hemp. Agusta 11, 2016.
> Gwamnatin Amirka ta Gudanar da Harkokin Kiwon Lafiya, Dokar Harkokin Drug.